Authors:
van Os, R
Sheridan, TM
Robinson, S
Drukteinis, D
Ferrara, JLM
Mauch, PM
Citation: R. Van Os et al., Immunogenicity of Ly5 (CD45)-antigens hampers long-term engraftment following minimal conditioning in a murine bone marrow transplantation model, STEM CELLS, 19(1), 2001, pp. 80-87
Authors:
Backstrand, KH
Ng, AK
Takvorian, RW
Jones, EL
Fisher, DC
Molnar-Griffin, BJ
Silver, B
Tarbell, NJ
Mauch, PM
Citation: Kh. Backstrand et al., Results of a prospective trial of mantle irradiation alone for selected patients with early-stage Hodgkins's disease, J CL ONCOL, 19(3), 2001, pp. 736-741
Citation: Ak. Ng et al., Costs and effectiveness of staging and treatment options in early-stage Hodgkin's disease, INT J RAD O, 50(4), 2001, pp. 979-989
Authors:
van Os, R
Robinson, S
Sheridan, T
Mauch, PM
Citation: R. Van Os et al., Granulocyte-colony stimulating factor impedes recovery from damage caused by cytotoxic agents through increased differentiation at the expense of self-renewal, STEM CELLS, 18(2), 2000, pp. 120-127
Authors:
Robinson, SN
Freedman, AS
Neuberg, DS
Nadler, M
Mauch, PM
Citation: Sn. Robinson et al., Loss of marrow reserve from dose-intensified chemotherapy results in impaired hematopoietic reconstitution after autologous transplantation: CD34(+),CD34(+)38(-), and week-6 CAFC assays predict poor engraftment, EXP HEMATOL, 28(12), 2000, pp. 1325-1333
Authors:
van Os, R
Avraham, H
Banu, N
Mauch, PM
Whater, J
Yang, YM
Du, B
Citation: R. Van Os et al., Recombinant adeno-associated virus-based vectors provide short-term ratherthan long-term transduction of primitive hematopoietic stem cells, STEM CELLS, 17(2), 1999, pp. 117-120
Citation: Ak. Ng et al., Decision analysis on alternative treatment strategies for favorable-prognosis, early-stage Hodgkin's disease, J CL ONCOL, 17(11), 1999, pp. 3577-3585
Authors:
Friedberg, JW
Neuberg, D
Stone, RM
Alyea, E
Jallow, H
LaCasce, A
Mauch, PM
Gribben, JG
Ritz, J
Nadler, LM
Soiffer, RJ
Freedman, AS
Citation: Jw. Friedberg et al., Outcome in patients with myelodysplastic syndrome after autologous bone marrow transplantation for non-Hodgkin's lymphoma, J CL ONCOL, 17(10), 1999, pp. 3128-3135
Citation: Ak. Ng et al., Laparotomy versus no laparotomy in the management of early-stage, favorable-prognosis Hodgkin's disease: A decision analysis, J CL ONCOL, 17(1), 1999, pp. 241-252
Authors:
Sleckman, BG
Mauch, PM
Ambinder, RF
Mann, R
Pinkus, GS
Kadin, ME
Sherburne, B
Perez-Atayde, A
Thior, I
Mueller, N
Citation: Bg. Sleckman et al., Epstein-Barr virus in Hodgkin's disease: Correlation of risk factors and disease characteristics with molecular evidence of viral infection, CANC EPID B, 7(12), 1998, pp. 1117-1121
Citation: Jm. Cosset et Pm. Mauch, The role of radiotherapy for early stage Hodgkin's disease: Limitations and perspectives, ANN ONCOL, 9, 1998, pp. 57-62
Authors:
Shulman, LN
Tarbell, NJ
Storen, E
Marcus, K
Mauch, PM
Citation: Ln. Shulman et al., Low-dose total body irradiation and G-CSF without hematopoietic stem cell support in the treatment of relapsed or refractory acute myelogenous leukemia (AML), or AML in second or subsequent remission, INT J RAD O, 42(5), 1998, pp. 1113-1117